Cx3cl1 Mouse siRNA Oligo Duplex (Locus ID 20312)
CAT#: SR426672
Cx3cl1 (Mouse) - 3 unique 27mer siRNA duplexes - 2 nmol each
Need single siRNA in bulk? 
                            Get a free quote
                        
SR426672 is the updated version of SR413227.
                
                
            CNY 4090.00
货期*
                        4周
                    规格
                        | Cited in 1 publication. | 
Product images
                    
                
                         推荐一起购买 (2)
                    
                    
                Specifications
| Product Data | |
| Purity | HPLC purified | 
| Quality Control | Tested by ESI-MS | 
| Sequences | Available with shipment | 
| Stability | One year from date of shipment when stored at -20°C. | 
| # of transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). | 
| Note | Single siRNA duplex (10nmol) can be ordered. | 
| Reference Data | |
| RefSeq | NM_009142 | 
| Synonyms | AB030188; ABCD-3; AI848747; CX3C; Cxc3; D8Bwg0439e; Scyd1 | 
| Components | Cx3cl1 (Mouse) - 3 unique 27mer siRNA duplexes - 2 nmol each (Locus ID 20312)Included - SR30004, Trilencer-27 Universal Scrambled Negative Control siRNA Duplex - 2 nmolIncluded - SR30005, RNAse free siRNA Duplex Resuspension Buffer - 2 ml | 
| Summary | Acts as a ligand for both CX3CR1 and integrins. Binds to CX3CR1 and to integrins ITGAV:ITGB3 and ITGA4:ITGB1. Can activate integrins in both a CX3CR1-dependent and CX3CR1-independent manner. In the presence of CX3CR1, activates integrins by binding to the classical ligand-binding site (site 1) in integrins. In the absence of CX3CR1, binds to a second site (site 2) in integrins which is distinct from site 1 and enhances the binding of other integrin ligands to site 1 (By similarity). The soluble form is chemotactic for T-cells and monocytes, but not for neutrophils. The membrane-bound form promotes adhesion of those leukocytes to endothelial cells. May play a role in regulating leukocyte adhesion and migration processes at the endothelium (PubMed:9177350, PubMed:10382755).[UniProtKB/Swiss-Prot Function] | 
| Performance Guranteed | OriGene guarantees that at least two of the three Dicer-Substrate duplexes in the kit will provide at least 70% or more knockdown of the target mRNA when used at 10 nM concentration by quantitative RT-PCR when the TYE-563 fluorescent transfection control duplex (cat# SR30002) indicates that >90% of the cells have been transfected and the HPRT positive control (cat# SR30003) provides 90% knockdown efficiency. For non-conforming siRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the siRNA kit. To arrange for a free replacement with newly designed duplexes, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled siRNA control (quantitative RT-PCR data required).  | 
        
Citations (1)
| The use of this RNAi has been cited in the following citations: | 
|---|
| 
                                                Targeting cardiomyocyte ADAM10 ectodomain shedding promotes survival early after myocardial infarction
                                                ,null,
                                                Nature Communications
                                                ,PubMed ID 36496449
                                                [Cx3cl1]
                                                 | 
                                        
Documents
| Product Manuals | 
| FAQs | 
| SDS | 
                         Customer
                                Reviews 
                    
                    
                                Loading...
                            
                        